Viewing nowTelmisartan Tablets 80 mg (Telmisartan)
Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

MFDS item code 201001685 · Notified 2010.02.25 · Insurance code 643902890
Treatment of essential hypertension; reduction of cardiovascular disease risk in high-risk patients
This medication is used in the treatment of essential hypertension. Additionally, it assists in reducing the risk of myocardial infarction, stroke, and cardiovascular mortality in patients aged 55 or older who cannot use ACE inhibitors due to high risk of cardiovascular disease. It is particularly effective in patients with a history of coronary artery disease, peripheral artery disease, stroke, or those with high-risk diabetes. Therefore, this medication is used to simultaneously improve the risk of hypertension and cardiovascular complications.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, monitoring of blood pressure is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause severe harm, especially to the fetus and newborn, during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals with allergies to this medication or its components, pregnant or breastfeeding women, patients with severe liver dysfunction, certain biliary disorders, hereditary angioedema, and specific kidney disorders. Caution should be exercised when used in the elderly, patients with hyperkalemia, patients with impaired liver function, patients with heart valve disease, patients with cerebrovascular disorders, patients with gastrointestinal disorders, and patients with renal vascular hypertension, and their condition should be monitored regularly. During treatment with this medication, various side effects may occur, such as infections, blood abnormalities, hyperkalemia, hypoglycemia, nervous system disorders, cardiovascular disorders, gastrointestinal disturbances, liver dysfunction, skin abnormalities, muscle and joint pain, and kidney dysfunction, so if any unusual symptoms occur, immediate consultation with healthcare professionals is necessary. Symptoms such as a sudden drop in blood pressure, shock, syncope, and loss of consciousness may occur, and immediate treatment is required if these symptoms arise, especially for users of diuretics or patients undergoing dialysis as they are at higher risk of hypotension. Kidney function and serum potassium levels should be regularly monitored, and hydration and electrolyte balance should be well managed. Additionally, it is advisable not to administer this medication within 24 hours prior to surgery, and caution is necessary if gastrointestinal disorders are present due to the risk of gastrointestinal bleeding. This medication may enhance hypotensive effects when used with other antihypertensive agents, and the risk of renal dysfunction or hyperkalemia may increase when used in conjunction with certain drugs; therefore, co-administration should follow healthcare provider recommendations. It is preferable for pregnant or breastfeeding women not to use this medication, and breastfeeding should be discontinued if necessary. Safety and effectiveness in children under 18 years have not been established, therefore it is not recommended. In the elderly, there is a risk of stroke due to excessive blood pressure reduction, so it should be administered cautiously. In case of overdose, symptoms may include hypotension, arrhythmias, dizziness, and acute renal failure; therefore, immediate medical attention should be sought for appropriate treatment. This medication should be stored out of the reach of children and kept sealed until just before administration to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. This helps to preserve the effectiveness and safety of the medication over time.
White or almost white, round, biconvex tablets
10 tablets/blister X 3, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Genuwon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.